home / stock / htgm / htgm news


HTGM News and Press, HTG Molecular Diagnostics Inc. From 06/14/21

Stock Information

Company Name: HTG Molecular Diagnostics Inc.
Stock Symbol: HTGM
Market: NASDAQ
Website: htgmolecular.com

Menu

HTGM HTGM Quote HTGM Short HTGM News HTGM Articles HTGM Message Board
Get HTGM Alerts

News, Short Squeeze, Breakout and More Instantly...

HTGM - HTG Completes Product Design Lock for its Planned Transcriptome Panel and Announces the Signing of the Three Early Adopter Program Collaboration Agreements

TUCSON, Ariz., June 14, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has completed product design lock for the HTG Transcriptome Panel and announced three Early A...

HTGM - HTG EdgeSeq Technology Highlighted in Several Posters Being Presented at the American Society of Clinical Oncology 2021 Virtual Conference

TUCSON, Ariz., May 24, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that its HTG EdgeSeq technology is highlighted in several posters being presented at the American...

HTGM - HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q1 2021 Results - Earnings Call Transcript

Start Time: 16:30 End Time: 16:51 HTG Molecular Diagnostics, Inc. (HTGM) Q1 2021 Earnings Conference Call May 13, 2021, 16:30 PM ET Company Participants John Lubniewski - President and CEO Shaun McMeans - SVP of Finance, Administration and CFO Monique Kosse - LifeSci Advisors Conference Call ...

HTGM - HTG Molecular EPS beats by $0.18, beats on revenue

HTG Molecular (HTGM): Q1 GAAP EPS of -$0.80 beats by $0.18.Revenue of $1.44M (-35.4% Y/Y) beats by $0.04M.Cash, cash equivalents and short-term available-for-sale securities totaled $30.8 million as of March 31, 2021, with current liabilities of approximately $8.3 million and non-current liab...

HTGM - HTG Molecular Diagnostics Reports First Quarter 2021 Results and Provides a Corporate Update

TUCSON, Ariz., May 13, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the first quarter ended March 31, 2021. Recent Business Highligh...

HTGM - HTG Molecular Diagnostics to Announce Q1 2021 Financial Results and Host Conference Call on Thursday, May 13

TUCSON, Ariz., May 04, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the quarter ended March 31, 2021 after the market close o...

HTGM - HTG Molecular Diagnostics Reports Preliminary First Quarter 2021 Financial Results

TUCSON, Ariz., April 05, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported certain preliminary financial results for the first quarter ended March 31, 2021. As discu...

HTGM - HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q4 2020 Results - Earnings Call Transcript

HTG Molecular Diagnostics, Inc. (HTGM) Q4 2020 Earnings Conference Call March 25, 2021 04:30 PM ET Company Participants Monique Kosse - LifeSci Advisors John Lubniewski - Chief Executive Officer Shaun McMeans - Chief Financial Officer Conference Call Participants Alex Nowak - Craig-Hallum Kri...

HTGM - HTG Molecular EPS misses by $1.15, beats on revenue

HTG Molecular (HTGM): FY GAAP EPS of -$4.51 misses by $1.15.Revenue of $8.55M (-55.5% Y/Y) beats by $0.12M.Cash, cash equivalents and short-term available-for-sale securities totaled $28.7 million as of December 31, 2020.Shares +2.2%.Press Release For further details see: HTG Molecular ...

HTGM - HTG Molecular Diagnostics Reports Full Year 2020 Results

TUCSON, Ariz., March 25, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the year ended December 31, 2020. Recent Business Highlights ...

Previous 10 Next 10